Next-Generation Biomarkers in Bladder Cancer: Urinary and Tissue Signatures
Bladder cancer is among the most common malignancies of the urinary tract and remains a major contributor to global cancer-related morbidity and mortality. Despite advances in diagnosis and treatment, its high recurrence rate necessitates lifelong surveillance. Although cystoscopy and urine cytology remain the diagnost...